A systematic review of in vitro models of drug-induced kidney injury

被引:21
|
作者
Irvine, Alasdair R. [1 ]
van Berlo, Damien [1 ,2 ]
Shekhani, Rawan [1 ]
Masereeuw, Rosalinde [1 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci UIPS, Div Pharmacol, David de Wied Bldg,Univ 99, NL-3584 CG Utrecht, Netherlands
[2] Natl Inst Publ Hlth & Environm, Antonie van Leeuwenhoeklaan 9, NL-3721 MA Bilthoven, Netherlands
基金
欧盟地平线“2020”;
关键词
In vitro models; Toxicity testing; Validation strategies; Systematic; review; Nephrotoxicity; NEPHROTOXIC COMPOUNDS; TOXICITY; LIVER; IFOSFAMIDE; BIOMARKERS; COCULTURE; HUMANS; CELLS;
D O I
10.1016/j.cotox.2021.06.001
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Drug-induced nephrotoxicity is a major cause of kidney dysfunction with potentially fatal consequences and can hamper the research and development of new pharmaceuticals. This emphasises the need for new methods for earlier and more accurate diagnosis to avoid drug-induced kidney injury. Here, we present a systematic review of the available approaches to study drug-induced kidney injury, as one of the most common reasons for drug withdrawal, in vitro. The systematic review approach was selected to ensure that our findings are as objective and reproducible as possible. A novel study quality checklist, named validation score, was developed based on published regulatory guidance and industrial perspectives, and models returned by the search strategy were analysed as per their overall complexity and the kidney region studied. Our search strategy returned 1731 articles supplemented by 337 from secondary sources, of which 57 articles met the inclusion criteria for final analysis. Our results show that the proximal tubule dominates the field (84%), followed by the glomerulus and Bowman's capsule (7%). Of all drugs investigated, the focus was most on cisplatin (n = 29, 50.1% of final inclusions). We found that with increasing model complexity the validation score increased, reflecting the value of innovative in vitro models. Furthermore, although the highly diverse usage of cell lines and modelling approaches prevented a strong statistical verification through a meta-analysis, our findings show the downstream potential of such approaches in personalised medicine and for rare diseases where traditional trials are not feasible.
引用
收藏
页码:18 / 26
页数:9
相关论文
共 50 条
  • [1] Kidney-based in vitro models for drug-induced toxicity testing
    João Faria
    Sabbir Ahmed
    Karin G. F. Gerritsen
    Silvia M. Mihaila
    Rosalinde Masereeuw
    Archives of Toxicology, 2019, 93 : 3397 - 3418
  • [2] Kidney-based in vitro models for drug-induced toxicity testing
    Faria, Joao
    Ahmed, Sabbir
    Gerritsen, Karin G. F.
    Mihaila, Silvia M.
    Masereeuw, Rosalinde
    ARCHIVES OF TOXICOLOGY, 2019, 93 (12) : 3397 - 3418
  • [3] Prediction of drug-induced kidney injury in drug discovery
    Kulkarni, Priyanka
    DRUG METABOLISM REVIEWS, 2021, 53 (02) : 234 - 244
  • [4] Drug-induced kidney injury: challenges and opportunities
    Connor, Skylar
    Roberts, Ruth A.
    Tong, Weida
    TOXICOLOGY RESEARCH, 2024, 13 (04)
  • [5] Biomarkers of drug-induced kidney injury
    Redahan, Lynn
    Murray, Patrick T.
    CURRENT OPINION IN CRITICAL CARE, 2017, 23 (06) : 463 - 469
  • [6] Epigenetic modifications in drug-induced liver injury: A systematic review
    de los Santos-Fernandez, Romina Lorena
    Segovia-Zafra, Antonio
    Paz-Lopez, Guillermo
    Matilla-Cabello, Gonzalo
    Niu, Hao
    alvarez-alvarez, Ismael
    Stephens, Camilla
    Gonzalez-Jimenez, Andres
    Lucena, M. Isabel
    Andrade, Raul J.
    Medina-Caliz, Inmaculada
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2025,
  • [7] A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity
    Qu, Yueyang
    An, Fan
    Luo, Yong
    Lu, Yao
    Liu, Tingjiao
    Zhao, Weijie
    Lin, Bingcheng
    BIOMATERIALS, 2018, 155 : 41 - 53
  • [8] Kidney Transporters and Drug-Induced Injury in Drug Development
    Radi, Zaher A.
    TOXICOLOGIC PATHOLOGY, 2020, 48 (06) : 721 - 724
  • [9] Metabolomics for early detection of drug-induced kidney injury: review of the current status
    Boudonck, Kurt J.
    Rose, Donald J.
    Karoly, Edward D.
    Lee, Douglas P.
    Lawton, Kay A.
    Lapinskas, Paula J.
    BIOANALYSIS, 2009, 1 (09) : 1645 - 1663
  • [10] Mechanisms and in vitro models of drug-induced cholestasis
    Eva Gijbels
    Vânia Vilas-Boas
    Neel Deferm
    Lindsey Devisscher
    Hartmut Jaeschke
    Pieter Annaert
    Mathieu Vinken
    Archives of Toxicology, 2019, 93 : 1169 - 1186